1. Home
  2. IDYA vs LPL Comparison

IDYA vs LPL Comparison

Compare IDYA & LPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$35.87

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

N/A

Current Price

$3.37

Market Cap

3.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
LPL
Founded
2015
1985
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.6B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
IDYA
LPL
Price
$35.87
$3.37
Analyst Decision
Strong Buy
Hold
Analyst Count
16
1
Target Price
$52.86
N/A
AVG Volume (30 Days)
1.4M
3.1M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
N/A
EPS
N/A
N/A
Revenue
$218,710,000.00
N/A
Revenue This Year
N/A
$1.35
Revenue Next Year
$201.05
$2.94
P/E Ratio
N/A
$25.64
Revenue Growth
3024.43
N/A
52 Week Low
$21.33
$3.34
52 Week High
$40.58
$5.83

Technical Indicators

Market Signals
Indicator
IDYA
LPL
Relative Strength Index (RSI) 50.34 31.57
Support Level $32.85 N/A
Resistance Level $38.17 $4.37
Average True Range (ATR) 1.45 0.13
MACD -0.47 -0.02
Stochastic Oscillator 4.70 1.40

Price Performance

Historical Comparison
IDYA
LPL

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.

Share on Social Networks: